Human immunodeficiency virus downregulates podocyte apoE expression

被引:14
|
作者
Arora, Shitij [1 ]
Husain, Mohammad [1 ]
Kumar, Dileep [1 ]
Patni, Hitesh [1 ]
Pathak, Shresh [1 ]
Mehrotra, Devi [1 ]
Reddy, Vivek Kathi [1 ]
Reddy, Lalit Rajeev [1 ]
Salhan, Divya [1 ]
Yadav, Anju [1 ]
Mathieson, Peter W. [2 ]
Saleem, Moin A. [2 ]
Chander, Praveen N. [3 ]
Singhal, Pravin C. [1 ]
机构
[1] N Shore Long Isl Jewish Med Ctr, Feinstein Inst Med Res, Ctr Immunol, Manhasset, NY USA
[2] Univ Bristol, Childrens Renal Unit, Bristol, Avon, England
[3] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA
基金
英国医学研究理事会;
关键词
apolipoprotein E; pelecan; mesangial cells; HEPARAN-SULFATE PROTEOGLYCANS; APOLIPOPROTEIN-A-I; CHOLESTEROL TRANSPORT; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; PEPTIDE ANALOGS; TRANSGENIC MICE; LIPID RAFTS; VIRAL ENTRY; HIV-1;
D O I
10.1152/ajprenal.90668.2008
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Arora S, Husain M, Kumar D, Patni H, Pathak S, Mehrotra D, Reddy VK, Reddy LR, Salhan D, Yadav A, Mathieson PW, Saleem MA, Chander PN, Singhal PC. Human immunodeficiency virus downregulates podocyte apoE expression. Am J Physiol Renal Physiol 297: F653-F661, 2009. First published June 24, 2009; doi:10.1152/ajprenal.90668.2008.-Apolipoprotein E (apoE) has been demonstrated to play an important role in providing protection against mesangial cell injury. In the present study, we evaluated the role of apoE and its associated downstream effects in human immunodeficiency virus (HIV)-associated nephropathy (HIVAN). Control (n = 6) and age-and sex-matched HIV-1 transgenic mice (Tg26, n = 6) were evaluated for their renal cortical expression of apoE. Renal tissue from Tg26 mice not only showed decreased apoE expression but also displayed downregulation of perlecan mRNA expression. In in vitro studies, conditionally immortalized human podocytes (CIHPs) were transduced with either NL4-3HIV (an HIV-1 construct lacking gag and pol, used for the development of Tg26 mouse model; NL4-3/CIHP) or empty vector (EV/CIHP); NL4-3/CIHPs and EV/CIHPs were studied for apoE mRNA expression. NL4-3/CIHPs showed reduction in apoE expression compared with EV/CIHPs. To evaluate the role of HIV-1 genes in the modulation of apoE expression, conditionally immortalized mouse podocytes (CIMPs) were transduced with individual HIV-1 gene constructs. Only nef-transduced CIMPs showed a decrease in apoE expression. To confirm this effect of nef in CIHPs, microarray analysis was performed in stable colonies of nef/CIHPs and EV/CIHPs. nef/CIHPs showed a 60% decrease in apoE and a 90% reduction in heparan sulfate mRNA expression. Moreover, nef transgenic mice showed a decrease in renal tissue expression of both apoE and perlecan. Both Tg26 and nef transgenic mice also showed areas of mesangial cell proliferation. These findings suggest that HIV-1-induced reduction in podocyte apoE expression and associated downregulation of podocyte perlecan might be contributing to mesangial cell (MC) phenotype in HIVAN.
引用
收藏
页码:F653 / F661
页数:9
相关论文
共 50 条
  • [21] Human immunodeficiency virus transmission-Mechanisms underlying the cell-to-cell spread of human immunodeficiency virus
    Calado, Marta
    Pires, David
    Conceicao, Carolina
    Santos-Costa, Quirina
    Anes, Elsa
    Azevedo-Pereira, Jose Miguel
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (06)
  • [22] Role of Interleukin 32 in Human Immunodeficiency Virus Reactivation and Its Link to Human Immunodeficiency Virus-Herpes Simplex Virus Coinfection
    Mesquita, Pedro M. M.
    Preston-Hurlburt, Paula
    Keller, Marla J.
    Vudattu, Nalini
    Espinoza, Lilia
    Altrich, Michelle
    Anastos, Kathryn
    Herold, Kevan C.
    Herold, Betsy C.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (04) : 614 - 622
  • [23] Interaction between human spermatozoids and the human immunodeficiency virus
    Cardona Maya, Walter
    Teresa Rugeles, Maria
    Cadavid, Angela P.
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (03): : 223 - 226
  • [24] Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy
    Mullins, James I.
    Frenkel, Lisa M.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 : S119 - S127
  • [25] μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies
    Sperber, Hannah S.
    Togarrati, Padma Priya
    Raymond, Kyle A.
    Bouzidi, Mohamed S.
    Gilfanova, Renata
    Gutierrez, Alan G.
    Muench, Marcus O.
    Pillai, Satish K.
    FASEB JOURNAL, 2020, 34 (11) : 14615 - 14630
  • [26] Distinct Evolutionary Pressures Underlie Diversity in Simian Immunodeficiency Virus and Human Immunodeficiency Virus Lineages
    Fischer, Will
    Apetrei, Cristian
    Santiago, Mario L.
    Li, Yingying
    Gautam, Rajeev
    Pandrea, Ivona
    Shaw, George M.
    Hahn, Beatrice H.
    Letvin, Norman L.
    Nabel, Gary J.
    Korber, Bette T.
    JOURNAL OF VIROLOGY, 2012, 86 (24) : 13217 - 13231
  • [27] Murine synaptosomal lipid raft protein and lipid composition are altered by expression of human apoE 3 and 4 and by increasing age
    Igbavboa, U
    Eckert, GP
    Malo, TM
    Studniski, AE
    Johnson, LNA
    Yamamoto, N
    Kobayashi, M
    Fujita, SC
    Appel, TR
    Müller, W
    Wood, WG
    Yanagisawa, K
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 225 - 232
  • [28] Clinical significance of ApoE expression in human gastric cancer
    Sakashita, Katsuya
    Tanaka, Fumiaki
    Zhang, Xiang
    Mimori, Koshi
    Kamohara, Yukio
    Inoue, Hiroshi
    Sawada, Tetsuji
    Hirakawa, Kosei
    Mori, Masaki
    ONCOLOGY REPORTS, 2008, 20 (06) : 1313 - 1319
  • [29] Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration
    Wright, TC
    Subbarao, S
    Ellerbrock, TV
    Lennox, JL
    Evans-Strickfaden, T
    Smith, DG
    Hart, CE
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (03) : 279 - 285
  • [30] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION BY SENSE TRANSCRIPTS ENCODING THE RETROVIRAL LEADER RNA
    BERKHOUT, B
    VANWAMEL, JLB
    ANTIVIRAL RESEARCH, 1995, 26 (02) : 101 - 115